topic-04002006 News Coverage on Pharmaceutical Industry - CTNow
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Tips for keeping medication costs down

    Tips for keeping medication costs down
    Amanda Greene relies on lidocaine patches to help manage the chronic pain that her Lupus causes. The anesthetic is available as a generic drug, typically sold at a substantially lower price. But this year, the 47-year-old Culver City resident says she's...
  • Top U.S. lawmaker urges Hospira not to flee tax system

    WASHINGTON (Reuters) - A senior U.S. senator said on Thursday he has written to Hospira Inc and urged the drug and medical device maker not to move its tax domicile abroad to save on U.S. taxes. Citing recent reports that Hospira plans to buy the medical...
  • Sanofi wins right to market MannKind's inhaled insulin drug Afrezza

    A French pharmaceutical company has agreed to pay up to $925 million for the right to market Afrezza, the recently approved inhaled insulin treatment for diabetes developed by MannKind Corp. of Valencia. Sanofi, based in Paris, said it would pay $150...
  • New Haven's Marinus Pharmaceuticals Goes Public

    Marinus Pharmaceuticals, an eight-person company working on a drug that may be effective against epileptic seizures, went public Thursday with a stock price of $8 a share. The shares traded as high as $8.16 on Thursday on the NASDAQ exchange, and...
  • AbbVie-Shire deal puts more pressure on Congress to overhaul tax code

    A massive pharmaceutical merger that will send the headquarters of a major U.S. drug maker overseas ramps up pressure on Congress to curtail the ability of companies to shelter foreign earnings. Illinois drug maker AbbVie Inc. said Friday that it...
  • An O.C. couple do the math: Same drug is far cheaper in Canada

    An O.C. couple do the math: Same drug is far cheaper in Canada
    Bent and Henni Christensen consider themselves patriotic Americans and strong supporters of Medicare. Nevertheless, the Huntington Beach couple buy most of their prescription drugs from an online Canadian pharmacy at prices much lower than in the United...
  • AbbVie to buy drugmaker Shire in nearly $55 billion deal

    AbbVie to buy drugmaker Shire in nearly $55 billion deal
    AbbVie Inc. has inked a nearly $55 billion deal to acquire drugmaker Shire PLC, the companies announced in a joint statement Friday morning. The deal, the largest of a year filled with merger and acquisition activity, will allow the North Chicago-...
  • American Ebola patients become serum test subjects

    American Ebola patients become serum test subjects
    There is no vaccine or proven treatment for patients stricken with Ebola, but two ailing Americans who were infected with the deadly virus while working in the West African nation of Liberia have become test subjects for an experimental serum that they...
  • Janus' Kozlowski seeks stocks immune to market malaise

    BOSTON (Reuters) - Concerned that trends in the economy may not help stock prices much, Janus Capital Group's Dan Kozlowski is looking for companies that can help themselves. As manager of the $4.2 billion Janus Contrarian Fund, Kozlowski has posted...
  • Close loopholes that let U.S. firms avoid taxes by using inversions

    Close loopholes that let U.S. firms avoid taxes by using inversions
    It's both endearing and infuriating to watch American corporate executives wring their hands about how the injustices of the U.S. tax code are forcing them — forcing them! — to reincorporate overseas through the procedure known as inversion....
  • AbbVie to buy drugmaker Shire for $55 billion

     AbbVie to buy drugmaker Shire for $55 billion
    AbbVie Inc. signed a nearly $55 billion deal to acquire drugmaker Shire PLC early Friday, a move that will allow it to substantially cut its corporate tax bill by moving its legal address to the United Kingdom. The deal, announced by both companies in a...